Anticancer properties of oxidation products of docosahexaenoic acid

Chemistry and Physics of Lipids

Volumn 153, Issue 1, 2008, Pages 47-56

  Siddiqui, Rafat A ^a,b,c   Harvey, Kevin ^a   Stillwell, William ^c  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Apoptosis; Docosahexaenoic acid; Isoprostane; Lipid oxidation

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CASPASE 3; CASPASE 9; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450; DOCOSAHEXAENOIC ACID; GAMMA LINOLENIC ACID; HYDROXYICOSATETRAENOIC ACID; ICOSAPENTAENOIC ACID; ISOPROSTANE DERIVATIVE; LINOLEIC ACID; LINOLENIC ACID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPASE A2; PHOSPHOLIPID; POLYUNSATURATED FATTY ACID; PROSTACYCLIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN E3; PROSTAGLANDIN F2; SATURATED FATTY ACID; STEARIDONIC ACID; THROMBOXANE A2; UNINDEXED DRUG; UNSATURATED FATTY ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; DRUG MECHANISM; FATTY ACID METABOLISM; FATTY ACID OXIDATION; HUMAN; LIPID ANALYSIS; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL LINE, TUMOR; DOCOSAHEXAENOIC ACIDS; HUMANS; LIPID PEROXIDATION; LIPID PEROXIDES; METABOLIC NETWORKS AND PATHWAYS; MITOCHONDRIA; NEOPLASMS; OXIDATION-REDUCTION; PHOSPHOLIPASES A2;

EID: 43049170474     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2008.02.009     Document Type: Article

References (137)

1. Aghdassi E., and Allard J.P. Breath alkanes as a marker of oxidative stress in different clinical conditions. Free Radical Biology & Medicine 28 (2000) 880-886
2. Ames B.N. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 221 (1983) 1256-1264
3. Arita M., Clish C.B., and Serhan C.N. The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids. Biochemical & Biophysical Research Communications 338 (2005) 149-157
4. Awasthi Y.C., Sharma R., Cheng J.Z., Yang Y., Sharma A., Singhal S.S., and Awasthi S. Role of 4-hydroxynonenal in stress-mediated apoptosis signaling. Molecular Aspects of Medicine 24 (2003) 219-230
5. Badawi A.F., El-Sohemy A., Stephen L.L., Ghoshal A.K., and Archer M.C. The effect of dietary n-3 and n-6 polyunsaturated fatty acids on the expression of cyclooxygenase 1 and 2 and levels of p21ras in rat mammary glands. Carcinogenesis 19 (1998) 905-910
6. Belikova N.A., Jiang J., Tyurina Y.Y., Zhao Q., Epperly M.W., Greenberger J., and Kagan V.E. Cardiolipin-specific peroxidase reactions of cytochrome C in mitochondria during irradiation-induced apoptosis. International Journal of Radiation Oncology, Biology, Physics 69 (2007) 176-186
7. Biswal S., Acquaah-Mensah G., Datta K., Wu X., and Kehrer J.P. Inhibition of cell proliferation and AP-1 activity by acrolein in human A549 lung adenocarcinoma cells due to thiol imbalance and covalent modifications. Chemical Research in Toxicology 15 (2002) 180-186
8. Bousserouel S., Brouillet A., Bereziat G., Raymondjean M., and Andreani M. Different effects of n-6 and n-3 polyunsaturated fatty acids on the activation of rat smooth muscle cells by interleukin-1 beta. Journal of Lipid Research 44 (2003) 601-611
9. Breckenridge W.C., Gombos G., and Morgan I.G. The lipid composition of adult rat brain synaptosomal plasma membranes. Biochimica et Biophysica Acta 266 (1972) 695-707
10. Bui T., and Straus D.S. Effects of cyclopentenone prostaglandins and related compounds on insulin-like growth factor-I and Waf1 gene expression. Biochimica et Biophysica Acta 1397 (1998) 31-42
11. Calviello G., Di Nicuolo F., Gragnoli S., Piccioni E., Serini S., Maggiano N., Tringali G., Navarra P., Ranelletti F.O., and Palozza P. n-3 PUFAs reduce VEGF expression in human colon cancer cells modulating the COX-2/PGE2 induced ERK-1 and -2 and HIF-1alpha induction pathway. Carcinogenesis 25 (2004) 2303-2310
12. Capdevila J.H., Falck J.R., and Harris R.C. Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. Journal of Lipid Research 41 (2000) 163-181
13. Carmichael J., Forrester L.M., Lewis A.D., Hayes J.D., Hayes P.C., and Wolf C.R. Glutathione S-transferase isoenzymes and glutathione peroxidase activity in normal and tumour samples from human lung. Carcinogenesis 9 (1988) 1617-1621
14. Castedo M., Ferri K., Roumier T., Metivier D., Zamzami N., and Kroemer G. Quantitation of mitochondrial alterations associated with apoptosis. Journal of Immunological Methods 265 (2002) 39-47
15. Chambon P. A decade of molecular biology of retinoic acid receptors. FASEB Journal 10 (1996) 940-954
16. Chandrasekharan N.V., Dai H., Roos K.L.T., Evanson N.K., Tomsik J., Elton T.S., and Simmons D.L. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 13926-13931
17. Chapkin R.S., Hong M.Y., Fan Y.Y., Davidson L.A., Sanders L.M., Henderson C.E., Barhoumi R., Burghardt R.C., Turner N.D., and Lupton J.R. Dietary n-3 PUFA alter colonocyte mitochondrial membrane composition and function. Lipids 37 (2002) 193-199
18. Chawla A., Repa J.J., Evans R.M., and Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files. Science 294 (2001) 1866-1870
19. Chen Z.Y., and Istfan N.W. Docosahexaenoic acid is a potent inducer of apoptosis in HT-29 colon cancer cells. Prostaglandins Leukotrienes & Essential Fatty Acids 63 (2000) 301-308
20. Chiu L.C.M., Wong E.Y.L., and Ooi V.E.C. Docosahexaenoic acid from a cultured microalga inhibits cell growth and induces apoptosis by upregulating Bax/Bcl-2 ratio in human breast carcinoma MCF-7 cells. Annals of the New York Academy of Sciences 1030 (2004) 361-368
21. Colquhoun A. Induction of apoptosis by polyunsaturated fatty acids and its relationship to fatty acid inhibition of carnitine palmitoyltransferase I activity in Hep2 cells. Biochemistry & Molecular Biology International 45 (1998) 331-336
22. Colquhoun A., and Schumacher R.I. Gamma-linolenic acid and eicosapentaenoic acid induce modifications in mitochondrial metabolism, reactive oxygen species generation, lipid peroxidation and apoptosis in Walker 256 rat carcinosarcoma cells. Biochimica et Biophysica Acta 1533 (2001) 207-219
23. Conquer J.A., and Holub B.J. Effect of supplementation with different doses of DHA on the levels of circulating DHA as non-esterified fatty acid in subjects of Asian Indian background. Journal of Lipid Research 39 (1998) 286-292
24. Corey E.J., Shih C., and Cashman J.R. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proceedings of the National Academy of Sciences of the United States of America 80 (1983) 3581-3584
25. Cuzzocrea S., Wayman N.S., Mazzon E., Dugo L., Di Paola R., Serraino I., Britti D., Chatterjee P.K., Caputi A.P., and Thiemermann C. The cyclopentenone prostaglandin 15-deoxy-delta(12,14)-prostaglandin J(2) attenuates the development of acute and chronic inflammation. Molecular Pharmacology 61 (2002) 997-1007
26. Das U.N. Tumoricidal action of cis-unsaturated fatty acids and their relationship to free radicals and lipid peroxidation. Cancer Letters 56 (1991) 235-243
27. Das U. A radical approach to cancer. Medical Science Monitor 8 (2002) RA79-RA92
28. de Urquiza A.M., Liu S., Sjoberg M., Zetterstrom R.H., Griffiths W., Sjovall J., and Perlmann T. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290 (2000) 2140-2144
29. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Reviews 20 (1999) 649-688
30. Ding W.-Q., Vaught J.L., Yamauchi H., and Lind S.E. Differential sensitivity of cancer cells to docosahexaenoic acid-induced cytotoxicity: the potential importance of down-regulation of superoxide dismutase 1 expression. Molecular Cancer Therapeutics 3 (2004) 1109-1117
31. Dumelin E.E., and Tappel A.L. Hydrocarbon gases produced during in vitro peroxidation of polyunsaturated fatty acids and decomposition of preformed hydroperoxides. Lipids 12 (1977) 894-900
32. Duran L., and Tappel A.L. Production of carbonyl compounds and sulfur compounds on irradiation of amino acids. Radiation Research 9 (1958) 498-501
33. Esterbauer H., Schaur R.J., and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biology & Medicine 11 (1991) 81-128
34. Fam S.S., Murphey L.J., Terry E.S., Zackert W.E., Chen Y., Gao L., Pandalai S., Milne G.L., Roberts L.J., Porter N.A., et al. Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid. Journal of Biological Chemistry 277 (2002) 36076-36084
35. Fan Y.-Y., Spencer T.E., Wang N., Moyer M.P., and Chapkin R.S. Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes. Carcinogenesis 24 (2003) 1541-1548
36. Fessel J.P., Porter N.A., Moore K.P., Sheller J.R., and Roberts II L.J. Discovery of lipid peroxidation products formed in vivo with a substituted tetrahydrofuran ring (isofurans) that are favored by increased oxygen tension. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 16713-16718
37. Fitzpatrick F.A., and Wynalda M.A. Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro. Journal of Biological Chemistry 258 (1983) 11713-11718
38. Forman B.M. The PPARs 2001: it's not over 'til the fat lady sings. 4-10 February 2001. Trends in Molecular Medicine 7 (2001) 331-332
39. Forman B.M., Tontonoz P., Chen J., Brun R.P., Spiegelman B.M., and Evans R.M. 15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell 83 (1995) 803-812
40. Forman H.J., Dickinson D.A., and Iles K.E. HNE-signaling pathways leading to its elimination. Molecular Aspects of Medicine 24 (2003) 189-194
41. Frankel E.N. Volatile lipid oxidation products. Progress in Lipid Research 22 (1983) 1-33
42. Fridovich I. Superoxide radical and superoxide dismutases. Annual Review of Biochemistry 64 (1995) 97-112
43. Fukushima M. Prostaglandin J2-anti-tumour and anti-viral activities and the mechanisms involved [erratum appears in Eicosanoids 4 (2) (1991) 119]. Eicosanoids 3 (1990) 189-199
44. Fukushima M. Biological activities and mechanisms of action of PGJ2 and related compounds: an update. Prostaglandins Leukotrienes & Essential Fatty Acids 47 (1992) 1-12
45. Gelmont D., Stein R.A., and Mead J.F. The bacterial origin of rat breath pentane. Biochemical & Biophysical Research Communications 102 (1981) 932-936
46. 2+-stimulated generation of reactive oxygen species by the respiratory chain. Biochemistry 38 (1999) 13279-13287
47. Gutteridge J.M. Free-radical damage to lipids, amino acids, carbohydrates and nucleic acids determined by thiobarbituric acid reactivity. International Journal of Biochemistry 14 (1982) 649-653
48. Halliwell B., and Gutteridge J.M. The importance of free radicals and catalytic metal ions in human diseases. Molecular Aspects of Medicine 8 (1985) 89-193
49. Halliwell B., and Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods in Enzymology 186 (1990) 1-85
50. Harman D. The aging process. Proceedings of the National Academy of Sciences of the United States of America 78 (1981) 7124-7128
51. Hong M.Y., Chapkin R.S., Davidson L.A., Turner N.D., Morris J.S., Carroll R.J., and Lupton J.R. Fish oil enhances targeted apoptosis during colon tumor initiation in part by downregulating Bcl-2. Nutrition & Cancer 46 (2003) 44-51
52. Honn K.V., and Marnett L.J. Requirement of a reactive alpha, beta-unsaturated carbonyl for inhibition of tumor growth and induction of differentiation by "A" series prostaglandins. Biochemical & Biophysical Research Communications 129 (1985) 34-40
53. Huang H., Starodub O., McIntosh A., Kier A.B., and Schroeder F. Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells. Journal of Biological Chemistry 277 (2002) 29139-29151
54. Hwang D. Fatty acids and immune responses-a new perspective in searching for clues to mechanism. Annual Review of Nutrition 20 (2000) 431-456
55. Janero D.R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radical Biology & Medicine 9 (1990) 515-540
56. Jemmerson R., Liu J., Hausauer D., Lam K.P., Mondino A., and Nelson R.D. A conformational change in cytochrome c of apoptotic and necrotic cells is detected by monoclonal antibody binding and mimicked by association of the native antigen with synthetic phospholipid vesicles. Biochemistry 38 (1999) 3599-3609
57. Jenski L.J., Sturdevant L.K., Ehringer W.D., and Stillwell W. Omega 3 fatty acids increase spontaneous release of cytosolic components from tumor cells. Lipids 26 (1991) 353-358
58. Kim I.K., Lee J.H., Sohn H.W., Kim H.S., and Kim S.H. Prostaglandin A2 and delta 12-prostaglandin J2 induce apoptosis in L1210 cells. FEBS Letters 321 (1993) 209-214
59. Kim H.J., Mun J.Y., Chun Y.J., Choi K.H., and Kim M.Y. Bax-dependent apoptosis induced by ceramide in HL-60 cells. FEBS Letters 505 (2001) 264-268
60. Kliewer S.A., Lenhard J.M., Willson T.M., Patel I., Morris D.C., and Lehmann J.M. A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83 (1995) 813-819
61. Klumpp S., and Krieglstein J. Serine/threonine protein phosphatases in apoptosis. Current Opinion in Pharmacology 2 (2002) 458-462
62. Knutson M.D., Handelman G.J., and Viteri F.E. Methods for measuring ethane and pentane in expired air from rats and humans. Free Radical Biology & Medicine 28 (2000) 514-519
63. Kosower N.S., and Kosower E.M. The glutathione status of cells. International Review of Cytology 54 (1978) 109-160
64. Kroemer G. Mitochondrial control of apoptosis: an introduction. Biochemical & Biophysical Research Communications 304 (2003) 433-435
65. Kumar G.S., and Das U.N. Free radical-dependent suppression of growth of mouse myeloma cells by alpha-linolenic and eicosapentaenoic acids in vitro. Cancer Letters 92 (1995) 27-38
66. Laneuville O., Breuer D.K., Xu N., Huang Z.H., Gage D.A., Watson J.T., Lagarde M., DeWitt D.L., and Smith W.L. Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)-octadecatrienoic acids from alpha-linolenic acid. Journal of Biological Chemistry 270 (1995) 19330-19336
67. Li P., Nijhawan D., Budihardjo I., Srinivasula S.M., Ahmad M., Alnemri E.S., and Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91 (1997) 479-489
68. Liu J., Yeo H.C., Doniger S.J., and Ames B.N. Assay of aldehydes from lipid peroxidation: gas chromatography-mass spectrometry compared to thiobarbituric acid. Analytical Biochemistry 245 (1997) 161-166
69. Liu G., Bibus D.M., Bode A.M., Ma W.Y., Holman R.T., and Dong Z. Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 7510-7515
70. Mattson M.P., Pedersen W.A., Duan W., Culmsee C., and Camandola S. Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases. Annals of the New York Academy of Sciences 893 (1999) 154-175
71. McMillin J.B., and Dowhan W. Cardiolipin and apoptosis. Biochimica et Biophysica Acta 1585 (2002) 97-107
72. Meister A., and Anderson M.E. Glutathione. Annual Review of Biochemistry 52 (1983) 711-760
73. Mengeaud V., Nano J.L., Fournel S., and Rampal P. Effects of eicosapentaenoic acid, gamma-linolenic acid and prostaglandin E1 on three human colon carcinoma cell lines. Prostaglandins Leukotrienes & Essential Fatty Acids 47 (1992) 313-319
74. Merendino N., Molinari R., Loppi B., Pessina G., D' Aquino M., Tomassi G., and Velottia F. Induction of apoptosis in human pancreatic cancer cells by docosahexaenoic acid. Annals of the New York Academy of Sciences 1010 (2003) 361-364
75. Merendino N., Loppi B., D'Aquino M., Molinari R., Pessina G., Romano C., and Velotti F. Docosahexaenoic acid induces apoptosis in the human PaCa-44 pancreatic cancer cell line by active reduced glutathione extrusion and lipid peroxidation. Nutrition & Cancer 52 (2005) 225-233
76. Milne G.L., Musiek E.S., and Morrow J.D. The cyclopentenone (A2/J2) isoprostanes-unique, highly reactive products of arachidonate peroxidation. Antioxidants & Redox Signaling 7 (2005) 210-220
77. Montine T.J., Neely M.D., Quinn J.F., Beal M.F., Markesbery W.R., Roberts L.J., and Morrow J.D. Lipid peroxidation in aging brain and Alzheimer's disease. Free Radical Biology & Medicine 33 (2002) 620-626
78. Moon Y., and Pestka J.J. Deoxynivalenol-induced mitogen-activated protein kinase phosphorylation and IL-6 expression in mice suppressed by fish oil. Journal of Nutritional Biochemistry 14 (2003) 717-726
79. Morrow J.D., Awad J.A., Boss H.J., Blair I.A., and Roberts II L.J. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proceedings of the National Academy of Sciences of the United States of America 89 (1992) 10721-10725
80. Morrow J.D., Minton T.A., Mukundan C.R., Campbell M.D., Zackert W.E., Daniel V.C., Badr K.F., Blair I.A., and Roberts II L.J. Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes. Journal of Biological Chemistry 269 (1994) 4317-4326
81. Morrow J.D., Awad J.A., Wu A., Zackert W.E., Daniel V.C., and Roberts II L.J. Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo. Journal of Biological Chemistry 271 (1996) 23185-23190
82. Nano J.-L., Nobili C., Girard-Pipau F., and Rampal P. Effects of fatty acids on the growth of Caco-2 cells. Prostaglandins Leukotrienes & Essential Fatty Acids 69 (2003) 207-215
83. Narayanan B.A., Narayanan N.K., and Reddy B.S. Docosahexaenoic acid regulated genes and transcription factors inducing apoptosis in human colon cancer cells. International Journal of Oncology 19 (2001) 1255-1262
84. Narayanan B.A., Narayanan N.K., Simi B., and Reddy B.S. Modulation of inducible nitric oxide synthase and related proinflammatory genes by the omega-3 fatty acid docosahexaenoic acid in human colon cancer cells. Cancer Research 63 (2003) 972-979
85. Narumiya S., Ohno K., Fujiwara M., and Fukushima M. Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei. Journal of Pharmacology & Experimental Therapeutics 239 (1986) 506-511
86. Neill A.R., and Masters C.J. Metabolism of fatty acids by ovine spermatozoa. J Reprod Fertil 34 (1973) 279-287
87. Newmeyer D.D., and Ferguson-Miller S. Mitochondria: releasing power for life and unleashing the machineries of death [erratum appears in Cell. (2003) Mar 21;(112)6:873]. Cell 112 (2003) 481-490
88. Nourooz-Zadeh J., Liu E.H., Anggard E., and Halliwell B. F4-isoprostanes: a novel class of prostanoids formed during peroxidation of docosahexaenoic acid (DHA). Biochemical & Biophysical Research Communications 242 (1998) 338-344
89. Oberley L.W., and Buettner G.R. Role of superoxide dismutase in cancer: a review. Cancer Research 39 (1979) 1141-1149
90. Oberley T.D., and Oberley L.W. Antioxidant enzyme levels in cancer. Histology & Histopathology 12 (1997) 525-535
91. Pacifici R.E., and Davies K.J. Protein, lipid and DNA repair systems in oxidative stress: the free-radical theory of aging revisited. Gerontology 37 (1991) 166-180
92. Padma M., and Das U.N. Effect of cis-unsaturated fatty acids on cellular oxidant stress in macrophage tumor (AK-5) cells in vitro. Cancer Letters 109 (1996) 63-75
93. Paradies G., Petrosillo G., Pistolese M., Di Venosa N., Serena D., and Ruggiero F.M. Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion. Free Radical Biology & Medicine 27 (1999) 42-50
94. Parcellier A., Gurbuxani S., Schmitt E., Solary E., and Garrido C. Heat shock proteins, cellular chaperones that modulate mitochondrial cell death pathways. Biochemical & Biophysical Research Communications 304 (2003) 505-512
95. Piche L.A., Cole P.D., Hadley M., van den Bergh R., and Draper H.H. Identification of N-epsilon-(2-propenal)lysine as the main form of malondialdehyde in food digesta. Carcinogenesis 9 (1988) 473-477
96. Pizzimenti S., Laurora S., Briatore F., Ferretti C., Dianzani M.U., and Barrera G. Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation. Free Radical Biology & Medicine 32 (2002) 233-245
97. Remacle J., Lambert D., Raes M., Pigeolet E., Michiels C., and Toussaint O. Importance of various antioxidant enzymes for cell stability. Confrontation between theoretical and experimental data. Biochemical Journal 286 (1992) 41-46
98. Ricote M., Li A.C., Willson T.M., Kelly C.J., and Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 391 (1998) 79-82
99. Ringbom T., Huss U., Stenholm A., Flock S., Skattebol L., Perera P., and Bohlin L. Cox-2 inhibitory effects of naturally occurring and modified fatty acids. Journal of Natural Products 64 (2001) 745-749
100. Roberts L.J., and Morrow J.D. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radical Biology & Medicine 28 (2000) 505-513
101. Roberts II L.J., Montine T.J., Markesbery W.R., Tapper A.R., Hardy P., Chemtob S., Dettbarn W.D., and Morrow J.D. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid. Journal of Biological Chemistry 273 (1998) 13605-13612
102. Roberts D.L., Goping I.S., and Bleackley R.C. Mitochondria at the heart of the cytotoxic attack. Biochemical & Biophysical Research Communications 304 (2003) 513-518
103. Rossi A., Elia G., and Santoro M.G. Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation. Proceedings of the National Academy of Sciences of the United States of America 94 (1997) 746-750
104. Ruvolo P.P., Deng X., Ito T., Carr B.K., and May W.S. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. Journal of Biological Chemistry 274 (1999) 20296-20300
105. Ruvolo P.P., Clark W., Mumby M., Gao F., and May W.S. A functional role for the B56 alpha-subunit of protein phosphatase 2A in ceramide-mediated regulation of Bcl2 phosphorylation status and function. Journal of Biological Chemistry 277 (2002) 22847-22852
106. Sagar P.S., and Das U.N. Cytotoxic action of cis-unsaturated fatty acids on human cervical carcinoma (HeLa) cells in vitro. Prostaglandins Leukotrienes & Essential Fatty Acids 53 (1995) 287-299
107. Salem N.J., Kim H.Y., and Yergey J.A. Docosahexaenoic acid: membrane function and metabolism. In: Simopoulos A.P., Kifer R.R., Martin R.E., and Barlow S.M. (Eds). The Health Effects of Polyunsaturated Fatty Acid in Seafoods (1986), Academic Press, New York 363-371
108. Schonberg S.A., Rudra P.K., Noding R., Skorpen F., Bjerve K.S., and Krokan H.E. Evidence that changes in Se-glutathione peroxidase levels affect the sensitivity of human tumour cell lines to n-3 fatty acids. Carcinogenesis 18 (1997) 1897-1904
109. Schonberg S.A., Lundemo A.G., Fladvad T., Holmgren K., Bremseth H., Nilsen A., Gederaas O., Tvedt K.E., Egeberg K.W., and Krokan H.E. Closely related colon cancer cell lines display different sensitivity to polyunsaturated fatty acids, accumulate different lipid classes and downregulate sterol regulatory element-binding protein 1. FEBS Journal 273 (2006) 2749-2765
110. Sellmayer A., Hrboticky N., and Weber P.C. Lipids in vascular function. Lipids 34 Suppl. (1999) S13-S18
111. Serhan C.N. Novel chemical mediators in the resolution of inflammation: resolvins and protectins. Anesthesiology Clinics 24 (2006) 341-364
112. Siddiqui R.A., Jenski L.J., Harvey K.A., Wiesehan J.D., Stillwell W., and Zaloga G.P. Cell-cycle arrest in Jurkat leukaemic cells: a possible role for docosahexaenoic acid. Biochemical Journal 371 (2003) 621-629
113. Siddiqui R.A., Shaikh S.R., Sech L.A., Yount H.R., Stillwell W., and Zaloga G.P. Omega 3-fatty acids: health benefits and cellular mechanisms of action. Mini-Reviews in Medicinal Chemistry 4 (2004) 859-871
114. Siddiqui R.A., Harvey K.A., Zaloga G.P., and Stillwell W. Modulation of lipid rafts by Ω-3 fatty acids in inflammation and cancer: implications for use of lipids during nutrition support. Nutrition in Clinical Practice 22 (2007) 74-88
115. Slater A.F., Nobel C.S., Maellaro E., Bustamante J., Kimland M., and Orrenius S. Nitrone spin traps and a nitroxide antioxidant inhibit a common pathway of thymocyte apoptosis. Biochemical Journal 306 (1995) 771-778
116. Smith M.A., Perry G., Richey P.L., Sayre L.M., Anderson V.E., Beal M.F., and Kowall N. Oxidative damage in Alzheimer's. Nature 382 (1996) 120-121
117. Smith W.L., Garavito R.M., and DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. Journal of Biological Chemistry 271 (1996) 33157-33160
118. Song W.-L., Lawson J.A., Reilly D., Rokach J., Chang C.-T., Giasson B., and FitzGerald G.A. Neurofurans: novel indices of oxidant stress derived from docosahexaenoic acid. Journal of Biological Chemistry 283 (2008) 6-16
119. Southorn P.A., and Powis G. Free radicals in medicine. II. Involvement in human disease. Mayo Clinic Proceedings 63 (1988) 390-408
120. Spector A.A., Kaduce T.L., Figard P.H., Norton K.C., Hoak J.C., and Czervionke R.L. Eicosapentaenoic acid and prostacyclin production by cultured human endothelial cells. Journal of Lipid Research 24 (1983) 1595-1604
121. Starkov A.A., Polster B.M., and Fiskum G. Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax. Journal of Neurochemistry 83 (2002) 220-228
122. Straus D.S., Pascual G., Li M., Welch J.S., Ricote M., Hsiang C.H., Sengchanthalangsy L.L., Ghosh G., and Glass C.K. 15-Deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. Proceedings of the National Academy of Sciences of the United States of America 97 (2000) 4844-4849
123. Suzuki H., Manabe S., Wada O., and Crawford M.A. Rapid incorporation of docosahexaenoic acid from dietary sources into brain microsomal, synaptosomal and mitochondrial membranes in adult mice. International Journal for Vitamin & Nutrition Research 67 (1997) 272-278
124. Trombetta A., Maggiora M., Martinasso G., Cotogni P., Canuto R.A., and Muzio G. Arachidonic and docosahexaenoic acids reduce the growth of A549 human lung-tumor cells increasing lipid peroxidation and PPARs. Chemico-Biological Interactions 165 (2007) 239-250
125. Tsujii M., and DuBois R.N. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83 (1995) 493-501
126. Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. Journal of Cellular Physiology 195 (2003) 158-167
127. Tyurina Y.Y., Kini V., Tyurin V.A., Vlasova I.I., Jiang J., Kapralov A.A., Belikova N.A., Yalowich J.C., Kurnikov I.V., and Kagan V.E. Mechanisms of cardiolipin oxidation by cytochrome c: relevance to pro- and antiapoptotic functions of etoposide. Molecular Pharmacology 70 (2006) 706-717
128. van Gurp M., Festjens N., van Loo G., Saelens X., and Vandenabeele P. Mitochondrial intermembrane proteins in cell death. Biochemical & Biophysical Research Communications 304 (2003) 487-497
129. Van Kuijk F.J., Holte L.L., and Dratz E.A. 4-Hydroxyhexenal: a lipid peroxidation product derived from oxidized docosahexaenoic acid. Biochimica et Biophysica Acta 1043 (1990) 116-118
130. VanMeter A.R., Ehringer W.D., Stillwell W., Blumenthal E.J., and Jenski L.J. Aged lymphocyte proliferation following incorporation and retention of dietary omega-3 fatty acids. Mechanisms of Ageing & Development 75 (1994) 95-114
131. von Haefen C., Wieder T., Gillissen B., Starck L., Graupner V., Dorken B., and Daniel P.T. Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells. Oncogene 21 (2002) 4009-4019
132. von Schacky C., Kiefl R., Marcus A.J., Broekman M.J., and Kaminski W.E. Dietary n-3 fatty acids accelerate catabolism of leukotriene B4 in human granulocytes. Biochimica et Biophysica Acta 1166 (1993) 20-24
133. Watkins S.M., Carter L.C., and German J.B. Docosahexaenoic acid accumulates in cardiolipin and enhances HT-29 cell oxidant production. Journal of Lipid Research 39 (1998) 1583-1588
134. Wiegand R.D., and Anderson R.E. Phospholipid molecular species of frog rod outer segment membranes. Experimental Eye Research 37 (1983) 159-173
135. Wu M., Harvey K.A., Ruzmetov N., Welch Z.R., Sech L., Jackson K., Stillwell W., Zaloga G.P., and Siddiqui R.A. Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. International Journal of Cancer 117 (2005) 340-348
136. Ye D., Zhang D., Oltman C., Dellsperger K., Lee H.-C., and VanRollins M. Cytochrome p-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary arterioles by activating large-conductance calcium-activated potassium channels. Journal of Pharmacology & Experimental Therapeutics 303 (2002) 768-776
137. Yin H., Brooks J.D., Gao L., Porter N.A., and Morrow J.D. Identification of novel autoxidation products of the n-3 fatty acid eicosapentaenoic acid in vitro and in vivo. Journal of Biological Chemistry 282 (2007) 29890-29901